Utilization of Rad51C promoter for transcriptional targeting of cancer cells

Cancer therapy that specifically targets malignant cells with minimal or no toxicity to normal tissue has been a long-standing goal of cancer research. Rad51 expression is elevated in a wide range of cancers and Rad51 promoter has been used to transcriptionally target tumor cells, however, a large s...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Yan, Xu, Yan, Zhang, Lei, Li, Zhen, Jiang, Ying, Tian, Xiao, Seluanov, Andrei, Gorbunova, Vera, Mao, Zhiyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4039114/
https://www.ncbi.nlm.nih.gov/pubmed/24742710

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4039114/
https://www.ncbi.nlm.nih.gov/pubmed/24742710

Ejemplares similares